---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-001359"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T15:44:47.252888+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Carmell to acquire Elevai Skincare assets for ~$1.1M stock, earnout, and assumption of liabilities

## Summary
- Purchase price includes ~$1.1M in Carmell common stock (with $100K escrow), ~$57K cash on inventory sale, 5% net sales earnout for 5 years, and $500K milestone.
- Assets include product portfolio with trailing 12-month revenue of ~$2.5M, ~$1.0M inventory, commercial team, and accounts receivable.
- Acquisition expected to close by January 17, 2025, subject to customary closing conditions.
- Carmell to issue unregistered shares as closing stock consideration with registration rights within 90 days.

## SEC filing metadata
- accession: 0000950170-25-001359
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025001359/0000950170-25-001359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025001359/ctcx-20241231.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-001359
- JSON: https://secwatch.observer/filing/0000950170-25-001359.json
- Plain text: https://secwatch.observer/filing/0000950170-25-001359.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.